• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Impact of Comorbidity on Outcomes and Overall Survival After Open and Minimal Invasive Esophagectomy for Locally Advanced Esophageal Cancer.

Impact of Comorbidity on Outcomes and Overall Survival After Open and Minimal Invasive Esophagectomy for Locally Advanced Esophageal Cancer.

James P Dolan, MD, Taranjeet Kaur, MBBS, Brian S Diggs, PhD, Renato A Luna, MD, Paul Schipper, MD, Brandon Tieu, MD, Brett C Sheppard, MD, John G Hunter, MD

Oregon Health & Science University

Introduction: Minimally invasive esophagectomy (MIE) was introduced with the intent of lessening the mortality and morbidity related to esophagectomy as compared to the open approach. More recently, comparisons have been made in regard to oncological equivalence between the two approaches. The aim of this study was to examine the impact of the Charlson Comorbidity Index on predicting outcomes and overall survival after Open and MIE.

Methods: We conducted a retrospective analysis of a prospective database between1995 and 2011. All patients who underwent esophagectomy for locally advanced esophageal cancer (stage II and III) were selected. A total of 146 patients were analyzed and separated into two groups, Open esophagectomy (Open) and MIE. Risk adjustment for each patient was performed using Charlson Comorbidity Index-Grade (CCI-G). The outcomes of interest were operative time, intraoperative estimated blood loss (EBL), lymph node harvest, length of hospital stay (LOS), major complications, 30-day mortality and overall survival. Multivariate linear, logistic and cox proportional hazard models were used to adjust for the effect of approach, age, gender, BMI, and CCI-G on the outcomes.

Results: Sixty four patients (44%) underwent Open while seventy one (49%) had MIE. An additional eleven (7%) had to be converted and were classified with the MIE for further analysis. There was no significant difference between MIE and Open in terms of operative time but MIE had less intraoperative EBL (mean 234 mL, p < 0.001). Lymph node harvest was also higher (mean 7 nodes, p < 0.001) and LOS was shorter for MIE (ratio 0.80, p = 0.018). Major complications occurred in 33% of patients in the MIE and 33% of patients in the Open group (p = 0.988) while 30-day mortality was 2% in MIE and 5% in Open (p = 0.459). Estimated survival at 3 years was 52% for MIE, 48% for Open and at 5 years 42% for MIE and 37% for Open (p = 0.513). Age, gender and BMI did not have any significant effect on the outcomes or overall survival. Charlson Comorbidity Index-Grade influenced outcomes with the operative time (mean 129 minutes, p = 0.004), LOS (ratio 2.3, p < 0.001), and major complications (odds ratio 10.1, p = 0.048) worse for CCI-G 3 compared to CCI-G 0. Overall survival was worse for CCI-G 1 in comparison with CCI-G 0 (hazard ratio 1.99, p = 0.027).

Conclusions: MIE is a safe alternative to Open esophagectomy for treatment of locally advanced esophageal cancer. Compared with Open esophagectomy, MIE decreases intraoperative EBL and LOS without increasing operative time, morbidity, or mortality related to the procedure. In addition, presence of comorbidities, as measured by CCI-G, increases operative time, length of hospital stay and post-operative complications while worsening overall survival.


Session: Podium Presentation

Program Number: S046

61

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals